Page 4 - Marcel Levi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

He told The Telegraph: “We are seeing elderly people who have fallen waiting five or six hours for an ambulance simply because there aren’t any available and the higher grade respiratory problems and chest problems get a higher priority.” The crisis is particularly acute in London where the capital’s busiest facility, the Royal London Hospital, has only one nurse for every three Covid patients being treated in intensive care, leaked correspondence shows. The facility in east London has reached “disaster medicine mode” and is no longer able to provide adequate critical care, accord...

UCLH staff spend New Year’s Eve kitting out makeshift ICUs in anticipation of a surge in Covid-19 patients. Photograph: Graeme Robertson/The Guardian One of London’s biggest hospitals has warned it is on track to become virtually Covid-only amid a surge in cases in the capital that has left it scrambling to convert operating theatres, surgical recovery areas and stroke wards into intensive care units for the very sick. As the daily coronavirus case numbers in the UK continued an apparently inexorable rise, hitting a record 55,892, with ...

UK scientists trial instant immunity antibody drug treatment for COVID-19 PTI London:  Scientists in the UK have begun trials of innovative antibody-drug treatments that they hope could provide instant protection against COVID-19. The University College London Hospitals NHS Trust (UCLH) said that the researchers in the Storm Chase study believe a Long Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to the SARS-CoV-2 coronavirus and prevent them developing COVID-19. The study...

UK scientists trial AstraZeneca's instant immunity antibody-drug treatment for COVID-19 Tthe researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to coronavirus PTI | December 27, 2020 | Updated 09:48 IST AZD7442 has the potential to be an important preventative and therapeutic medicine against COVID-19 Scientists in the UK have begun trials of innovative antibody-drug treatments that they hope could provide instant protection against COVID-1...